varenicline has been researched along with Amphetamine Abuse in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crooks, PA; Dwoskin, LP; Kangiser, MM; Stairs, DJ; Zheng, G | 1 |
Briones, M; Cook, R; Fang, WB; Furst, B; Heinzerling, K; Moody, DE; Shoptaw, S; Swanson, AN; Tsuang, J; Worley, M | 1 |
Ayers, C; Chan, B; Freeman, M; Kansagara, D; Kondo, K; Montgomery, J; Paynter, R | 1 |
Bennett, RS; De La Garza, R; Mahoney, JJ; Newton, TF; Thompson-Lake, DG; Verrico, CD | 1 |
De La Garza, R; Kalechstein, AD; Mahoney, JJ; Verrico, CD | 1 |
Barrett, ST; Bevins, RA; Chou, S; Pittenger, ST | 2 |
Lyon, GJ | 1 |
1 review(s) available for varenicline and Amphetamine Abuse
Article | Year |
---|---|
Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis.
Topics: Amphetamine-Related Disorders; Anticonvulsants; Antidepressive Agents; Antipyretics; Drug Therapy; Humans; Methylphenidate; Naltrexone; Outcome Assessment, Health Care; Varenicline | 2019 |
3 trial(s) available for varenicline and Amphetamine Abuse
Article | Year |
---|---|
Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial.
Topics: Adult; Amphetamine-Related Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Methamphetamine; Nicotinic Agonists; Treatment Outcome; Varenicline | 2018 |
Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers.
Topics: Adult; Amphetamine-Related Disorders; Behavior, Addictive; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Methamphetamine; Nicotinic Agonists; Quinoxalines; Treatment Outcome; Varenicline; Young Adult | 2014 |
Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users.
Topics: Acoustic Stimulation; Adult; Amphetamine-Related Disorders; Auditory Perception; Benzazepines; Female; Humans; Male; Methamphetamine; Neuropsychological Tests; Nicotinic Agonists; Nootropic Agents; Photic Stimulation; Quinoxalines; Reaction Time; Time Factors; Treatment Outcome; Varenicline; Visual Perception | 2014 |
4 other study(ies) available for varenicline and Amphetamine Abuse
Article | Year |
---|---|
Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Lobeline; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Substance-Related Disorders; Varenicline | 2018 |
The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats.
Topics: Amphetamine-Related Disorders; Animals; Catheters, Indwelling; Central Nervous System Stimulants; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Female; Methamphetamine; Motor Activity; Nicotinic Agonists; Psychotropic Drugs; Random Allocation; Rats, Sprague-Dawley; Self Administration; Treatment Outcome; Varenicline | 2016 |
The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in male rats.
Topics: Amphetamine-Related Disorders; Analysis of Variance; Animals; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Locomotion; Male; Methamphetamine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Varenicline | 2017 |
Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission.
Topics: Adult; Amphetamine-Related Disorders; Benzazepines; Borderline Personality Disorder; Depressive Disorder, Major; Drug Partial Agonism; Female; Humans; Irritable Mood; Methamphetamine; Nicotinic Agonists; Paranoid Disorders; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2008 |